KADCYLA

Hoffmann-La Roche Limited🇨🇦 Health Canada

Approval Id: b6e8b036a691f2db
Drug Approval Canada Name: KADCYLA
Product Name: KADCYLA
Status: Marketed
Status Date: 2018-10-24
Original Market Date: 2018-10-24
Din: 02473224
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 10:00.00
Atc Original: L01FD03 TRASTUZUMAB EMTANSINE
Atc Name: l 01 fd 03
Aig Number: 0154730003
Company Name: Hoffmann-La Roche Limited
Company Address: 7070 Mississauga Road, Mississauga, Ontario, Canada, L5N 5M8

TRASTUZUMAB EMTANSINE

160 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b6e8b036a691f2db

Type

Standard